-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ibezapolstat in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ibezapolstat in Clostridioides difficile Infections (Clostridium difficile Associated Disease) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ibezapolstat in Clostridioides difficile Infections (Clostridium...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ibezapolstat
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ibezapolstat Drug Details Ibezapolstat (ACX-362E) is under development for the treatment of Clostridium difficile...
-
Product Insights
Calcitonin Gene Related Peptide (CGRP) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Calcitonin Gene-Related Peptide (CGRP) is derived mainly from the cell bodies of motor neurons when synthesized in the ventral horn of the spinal cord and contributes to the regeneration of nervous tissue after injury. CGRP plays an important role in cardiovascular homeostasis and nociception. The CGRP pipeline market research report provides comprehensive information on the CGRP targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also...
-
Product Insights
Clostridium Difficile Infections (Clostridium Difficile Associated Disease) Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Clostridium difficile Infections (Clostridium difficile Associated Disease) Global Clinical Trials Review, H1, 2019" provides an overview of Clostridium difficile Infections (Clostridium difficile Associated Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Clostridium difficile Infections (Clostridium difficile Associated Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7...